Article
Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer.
The Journal of pathology - 1 Jan 2023
Eyck Ben M, Jansen Maurice Phm, Noordman Bo Jan, Atmodimedjo Peggy N, van der Wilk Berend J, Martens John Wm, Helmijr Jean A, Beaufort Corine M, Mostert Bianca, Doukas Michail, Wijnhoven Bas Pl, Lagarde Sjoerd M, van Lanschot J Jan B, Dinjens Winand Nm
Abstract excerpt
Active surveillance instead of standard surgery after neoadjuvant chemoradiotherapy (nCRT) has been proposed for patients with oesophageal cancer. Circulating tumour DNA (ctDNA) may be used to facilitate selection of patients for surgery. We show that detection of ctDNA after nCRT seems highly suggestive of major residual disease. Tumour biopsies and blood samples were taken before, and 6 and 12 weeks after,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
